Table 2.

Serum 25(OH)D levels and obesity markers at baseline and after intervention.

Variables		Placebo (N = 49)	Vitamin D (N = 76)	P*
25(OH)D (ng/ml)	Baseline	14.16 ± 5.01	14.61 ± 4.86	0.624
	3 months	14.62 ± 4.78	34.09 ± 3.58
	MD	0.46 ± 1.45	19.49 ± 4.66	<0.001
	% MD	5.23 ± 13.01	163 ± 106.57	<0.001
	P**	0.031	<0.001
Weight (kg)	Baseline	98.11 ± 21.94	103.02 ± 23.95	0.250
	3 months	88.50 ± 20.88	91.89 ± 22.19
	MD	9.61 ± 2.91	11.13 ± 2.57	0.003
	% MD***	−9.93 ± 2.63	−10.92 ± 1.97	0.027
	P**	<0.001	<0.001
BMI (kg/m2)	Baseline	34.00 ± 6.37	35.26 ± 7.32	0.327
	3 months	30.63 ± 5.99	31.44 ± 6.80
	MD	3.36 ± 1.03	3.81 ± 0.85	0.009
	% MD***	−9.93 ± 2.63	−10.92 ± 1.97	0.027
	P**	<0.001	<0.001
REE (kcal)	Baseline	1536.59 ± 383.66	1604.76 ± 435.99	0.373
	3 months	1416.69 ± 38357	1486.03 ± 442.78
	MD	119.90 ± 22.60	118.74 ± 21.32	0.772
	% MD***	−8.28 ± 2.63	−8.06 ± 2.95	0.674
	P**	<0.001	<0.001
Fat Mass (%)	Baseline	38.04 ± 7.42	37.54 ± 7.77	0.721
	3 months	33.14 ± 6.79	32.07 ± 7.61
	MD	4.90 ± 0.96	5.47 ± 1.03	0.002
	% MD***	−13.05 ± 2.21	−15.10 ± 3.71	<0.001
	P**	<0.001	<0.001

MD, Mean differences. Values are presented as mean ± SD.

^*P-value for Independent sample t-test.

^**P-value for Paired t-test.

^***100^*(After-Baseline)/Baseline.